If You Invested in Nakamoto Inc WTS 5/31/29 (NAKAW)

Kindly MD, Inc. (NAKAW) – Tradeable Warrants Overview

Kindly MD, Inc. is a Utah corporation whose securities include tradeable warrants to purchase shares of common stock, par value $0.001 per share. These warrants trade under the symbol NAKAW on the OTC Pink Market, as disclosed in the company’s Current Reports on Form 8-K and 8-K/A. The warrants are linked to Kindly MD, Inc.’s common stock, which is referenced in the same filings under a separate symbol.

The company identifies itself in SEC filings as an emerging growth company under applicable U.S. securities regulations. Kindly MD, Inc. is organized in Utah and lists its principal location in Salt Lake City, Utah. Its Commission File Number is 001-42103 and its IRS Employer Identification Number is 84-3829824, as set out in its Form 8-K and Form 8-K/A cover pages.

Corporate Transactions and Structure

According to an amended Current Report on Form 8-K/A, Kindly MD, Inc. entered into an Agreement and Plan of Merger with Kindly Holdco Corp (a direct, wholly owned subsidiary of Kindly MD, Inc.), Nakamoto Holdings Inc., and Wade Rivers, LLC. Under this agreement, Kindly Holdco Corp merged with and into Nakamoto Holdings Inc., with Nakamoto surviving as a wholly owned subsidiary of Kindly MD, Inc. The filing states that this merger (referred to as the “Merger”) closed on August 14, 2025.

The same Form 8-K/A describes related transactions, including the issuance of common stock and pre-funded warrants (referred to as the “PIPE Transaction”) and the issuance of convertible debentures (the “Debt Transaction”). These transactions are discussed in the company’s Initial Form 8-K and subsequent amendment, together with references to additional disclosure in the company’s information statement, annual report, and quarterly report.

Capital Structure and Debenture Redemption

In a separate Current Report on Form 8-K, Kindly MD, Inc. reports that it issued a notice of redemption to the holder of a Secured Convertible Debenture dated August 15, 2025. Under the terms described in that filing, the company states that it will redeem all amounts outstanding under the debenture that have not been converted on or before a specified redemption date. The filing explains that the redemption amount is based on 100% of the outstanding principal amount plus a 1.5% payment premium, and notes that there will be no accrued or unpaid interest due and payable as of the redemption date.

These disclosures highlight that Kindly MD, Inc.’s capital structure includes common stock, tradeable warrants to purchase common stock (NAKAW), pre-funded warrants, and convertible debentures, each documented in its SEC filings. The warrants represented by NAKAW are one element of this broader capital framework.

Regulatory Filings and Disclosures

Kindly MD, Inc. uses its SEC filings to provide information about its corporate transactions, financial reporting, and risk disclosures. The Form 8-K/A notes that the company is providing supplemental risk factors, including matters related to cybersecurity, data privacy, and a bitcoin treasury strategy, as well as updated Management’s Discussion and Analysis and Information about Nakamoto. These materials are incorporated by reference into the Form 8-K/A as exhibits and are intended to supplement prior filings such as the company’s definitive information statement, annual report on Form 10-K, and quarterly report on Form 10-Q.

For investors and observers focusing on the NAKAW warrants, these filings provide context on the company’s structure, the merger with Nakamoto Holdings Inc., and the financing and debt arrangements that may be relevant to understanding the underlying common stock to which the warrants relate.

NAKAW as an OTC Pink Market Security

The tradeable warrants to purchase shares of Kindly MD, Inc. common stock, par value $0.001 per share, are explicitly identified in the company’s Form 8-K and Form 8-K/A as trading on the OTC Pink Market under the symbol NAKAW. This classification indicates that NAKAW is quoted on an over-the-counter market rather than a national securities exchange, as reflected in the SEC cover pages.

Because NAKAW represents warrants rather than common stock itself, its value and characteristics are tied to the terms of the warrants and the performance and capital structure of Kindly MD, Inc., as described in its public filings. The SEC reports referenced above are the primary sources for understanding how these warrants fit into the company’s overall financing and merger transactions.